Tuesday, March 31, 2015: 9:30 AM-10:45 AM
International Ballroom (Hilton Chicago)
Description: Scientific Plenary IX will showcase original research aimed at improving short-term perioperative outcomes for women undergoing surgery for gynecologic cancer and a discussion of the value of the American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP). This plenary session will also feature original research on 1) the impact of adjuvant therapies in ovarian and endometrial cancer, 2) the impact of bariatric surgery on cancer-related pathways, and 3) the efforts to correctly identify genes associated (or not associated) with ovarian cancer risks
Moderators: Jamie N. Bakkum-Gamez, MD, Mayo Clinic, Rochester, MN and Stephen L. Rose, MD, University of Wisconsin School of Medicine and Public Health, Madison, WI
9:30 AM
Introductory Remarks
J. N. Bakkum-Gamez1 and S. L. Rose2
1Mayo Clinic, Rochester, MN, 2University of Wisconsin School of Medicine and Public Health, Madison, WI
9:35 AM
Incidence of VTE by type of gynecologic malignancy in the National Surgical Quality Improvement Program
A. Graul1, E. M. Ko2 and N. A. Latif3
1Hospital of the University of Pennsylvania, Philadelphia, PA, 2University of Pennsylvania, Penn Medicine, Philadelphia, PA, 3University of Pennsylvania, Philadelphia, PA
9:44 AM
A prediction model for surgical mortality and serious morbidity after primary debulking surgery
N. A. Latif1, J. Kobie2, N. Mitra2, R. A. Burger1, M. A. Morgan1 and E. M. Ko3
1University of Pennsylvania, Philadelphia, PA, 2Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 3University of Pennsylvania, Penn Medicine, Philadelphia, PA
9:53 AM
Distillation IX
S. C. Dowdy
Mayo Clinic, Rochester, MN
10:02 AM
Impact of treatment-induced neutropenia and thrombocytopenia on survival in patients with advanced ovarian cancer treated with chemotherapy plus bevacizumab: an NRG Oncology/Gynecologic Oncology Group ancillary data study
K. S. Tewari1, J. Java2, R. N. Eskander3, B. J. Monk4 and R. A. Burger5
1UC Irvine Medical Center, Orange, CA, 2Gynecologic Oncology Group Statistical and Data Center, Buffalo, NY, 3University of California at Irvine Medical Center, Orange, CA, 4University of Arizona Cancer Center, Phoenix, AZ, 5University of Pennsylvania, Philadelphia, PA
10:11 AM
Changes in metabolic profiles before and after bariatric surgery in high risk morbidly obese women: obesity-related carcinogenesis is not all about hormones
S. C. Modesitt1, P. T. Hallowell2, K. L. Hoehn3, J. K. Slack-Davis4, S. L. Kelley4, S. Arapovic5 and M. Shupnik3
1University of Virginia Health System, Charlottesville, VA, 2University of Virginia Health System, Charlotesville, VA, 3University of Virginia School of Medicine, Charlottesville, VA, 4University of Virginia, Charlottesville, VA, 5University of Virginia Medical Center, Charlottesville, VA
10:29 AM
KRAS variant rs61764370 is not associated with ovarian cancer risk or survival in the Ovarian Cancer Association Consortium (OCAC) or Consortium of Modifiers of BRCA1 and BRCA2 (CIMBA)
A. Berchuck1, F. H. van der Baan2, S. E. Johnatty3, G. Chenevix-Trench4, P. D. P. Pharoah5, M. A. Rookus2 and E. Goode6
1Duke University Medical Center, Durham, NC, 2Netherlands Cancer Institute, Amsterdam, Netherlands, 3Department of Genetics, Brisbane, Australia, 4Queensland Institute of Medical Research, Brisbane, Australia, 5University of Cambridge, Cambridge, United Kingdom, 6Mayo Clinic, Rochester, MN
10:46 AM
Moderator
J. N. Bakkum-Gamez
Mayo Clinic, Rochester, MN
10:46 AM
Moderator
S. L. Rose
University of Wisconsin School of Medicine and Public Health, Madison, WI
